NI of Therapy na LT Malaya of NAMSU - Chr. Non-Communicable

Kharkiv 61039

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Risk, Chronic Kidney Disease, Inflammation, Obesity, Overweight

Studies at this site

• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed